SYSMEX INOSTICS INC.

In News

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia - Nature

Nature - Nov 24, 2025

Exact Sciences founders raise $56M for new liquid biopsy venture - MedTech Dive

MedTech Dive - Nov 17, 2022

Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML) - FNIH

FNIH - Jun 06, 2023

At a CAGR of 18.1% Liquid Biopsy Market size is Expected to - GlobeNewswire

GlobeNewswire - Nov 04, 2022

Emerging Growth Patterns Driving Expansion in the Liquid Biopsy for Cancer Diagnostics Market - openPR.com

openPR.com - Apr 21, 2026

Pap test fluids used in gene-based screening test for two gyn cancers - EurekAlert!

EurekAlert! - Mar 22, 2018

Patient-centric thresholding of Cobas® EGFR mutation Test v2 for surveillance of EGFR-mutated metastatic non-small cell lung cancer - Nature

Nature - Aug 06, 2024

43 Top Biopharma Startups and Companies in Germany - EU-Startups

EU-Startups - Nov 26, 2021

Major Industry Participants Consolidating Their Presence in the Multi Cancer Early Detection Market - openPR.com

openPR.com - Apr 29, 2026

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer - Nature

Nature - Nov 23, 2018

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment